Symptoms Comparison: Suture-stent vs Conventional Double-J Stents After Ureterorenoscopy. A Prospective Randomized Trial

December 28, 2020 updated by: Andrea Bosio, Azienda Ospedaliera Città della Salute e della Scienza di Torino

Comparison Between Symptomps Related to Pigtail Suture Stent Versus Conventional Double J After Ureterorenoscopy for Stone Treatment. A Prospective Randomized Trial

Double J ureteral stents (DJ) are widely used in urological practice and commonly inserted after most of ureteroscopies. Stent-related symptoms (SRS) represent a major issue. Many research lines have been explored with the aim of decreasing SRS: Vogt et al. projected a self-made pigtail suture stent (PSS) replacing the distal pigtail with a 0.3 Fr suture reaching the bladder, showing decreased SRS and good tolerance. To date, these promising results hasn't been confirmed by a prospective randomized controlled trial (RCT) involving a marketed PSS. Thus, we designed a prospective single-blind RCT to compare SRS caused by marketed PSS and conventional DJ after uncomplicated URS for stone treatment.

Study Overview

Study Type

Interventional

Enrollment (Actual)

84

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Turin, Italy, 10126
        • AOU Città della Salute e della Scienza

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ureteral or renal stones < 2 cm needing treatment through semirigid or flexible URS and laser lithotripsy
  • stone-free procedure and absence of intraprocedural complications
  • WHO performance status 0-2

Exclusion Criteria:

  • significant residual fragments at the end of the procedure
  • intraprocedural complications (e.g. ureteral damage or stricture)
  • indwelling double J stent
  • acute kidney failure
  • urinary tract infection
  • urinary tract abnormalities
  • pathologies or medications potentially influencing voiding pattern and pain perception

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: suture stent
suture stent positioning after ureteroscopy. Intervention: administration of USSQ questionnaire.
Administration of USSQ Symptoms questionnaire to patients with two different type of stents after ureteroscopy
Active Comparator: conventional double-J stent
conventional double-J stent positioning after ureteroscopy. Intervention: administration of USSQ questionnaire.
Administration of USSQ Symptoms questionnaire to patients with two different type of stents after ureteroscopy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Urinary Symptom Index Score
Time Frame: 14 days
to compare Urinary Symptom Index Score (sum of USSQ Urinary symptoms scores) of suture stent and double J group, 2 weeks after surgery.
14 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
USSQ domains' scores
Time Frame: 14 days
to compare USSQ domains' scores of suture stent and double J group, 2 weeks after surgery
14 days
USSQ domains' scores
Time Frame: 2 days
to compare USSQ domains' scores of suture stent and double J group, 2 days after surgery
2 days
USSQ single answers
Time Frame: 14 day
to compare USSQ single answers of suture stent and double J group, 2 weeks after surgery
14 day
USSQ single answers
Time Frame: 2 days
to compare USSQ single answers of suture stent and double J group, 2 days after surgery
2 days
2 weeks USSQ domains' subscores adjusted for baseline
Time Frame: 6 weeks
to compare 2 weeks USSQ domains' subscores adjusted for baseline of suture stent and double J group
6 weeks
complications and adverse events
Time Frame: 2 weeks
to compare complications and adverse events of suture stent and double J group
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andrea Bosio, Azienda Ospedaliera Citta Della Salute E Della Scienza Di Torino

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 8, 2020

Primary Completion (Actual)

November 2, 2020

Study Completion (Actual)

December 16, 2020

Study Registration Dates

First Submitted

November 11, 2017

First Submitted That Met QC Criteria

November 11, 2017

First Posted (Actual)

November 17, 2017

Study Record Updates

Last Update Posted (Actual)

December 30, 2020

Last Update Submitted That Met QC Criteria

December 28, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Administration of USSQ Symptoms questionnaire after stent positioning

3
Subscribe